With 1.0 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.7 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $0.1449 whereas the lowest price it dropped to was $0.1286. The 52-week range on ACON shows that it touched its highest point at $6.75 and its lowest point at $0.10 during that stretch. It currently has a 1-year price target of $1.15. Beta for the stock currently stands at 0.47.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ACON was up-trending over the past week, with a rise of 15.93%, but this was down by -18.28% over a month. Three-month performance dropped to -21.05% while six-month performance fell -50.24%. The stock lost -95.89% in the past year, while it has lost -95.47% so far this year. A look at the trailing 12-month EPS for ACON yields -2.27 with Next year EPS estimates of -0.40. For the next quarter, that number is -0.12. This implies an EPS growth rate of 90.76% for this year and 51.53% for next year.
Float and Shares Shorts:
At present, 10.44 million ACON shares are outstanding with a float of 10.42 million shares on hand for trading. On 2024-10-31, short shares totaled 0.43 million, which was 427.00000000000006 higher than short shares on 1727654400. In addition to Dr. Jeffrey John Thramann M.D. as the firm’s Executive Chairman, Mr. Brent Ness serves as its CEO, President & Director.
Institutional Ownership:
Through their ownership of 0.03575 of ACON’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-06-30, ACON reported revenue of $14407.0 and operating income of -$1295958.0. The EBITDA in the recently reported quarter was -$1245626.0 and diluted EPS was -$0.15.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With ACON analysts setting a high price target of 1.3 and a low target of 1.3, the average target price over the next 12 months is 1.3. Based on these targets, ACON could surge 828.57% to reach the target high and rise by 828.57% to reach the target low. Reaching the average price target will result in a growth of 828.57% from current levels.
Analysts have provided yearly estimates in a range of -$0.74737 being high and -$0.88263 being low. For ACON, this leads to a yearly average estimate of -$0.815.
